来自瘤相关巨细胞的细胞外囊泡:对瘤进展和新兴治疗策略的含义
Carolinne Souza Amorim1, João Alfredo Moraes1, Mariana Renovato-Martins2
1Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Experimental cell research
|December 13, 2025
概括
巨细胞衍生的细胞外囊泡 (EVs) 可以影响瘤进展,转移和治疗耐药性. 本综述探讨了它们作为抗癌疗法的双重作用和潜力.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 众所周知,来自瘤细胞的细胞外囊泡 (EV) 可以促进癌症的进展.
- 巨细胞是瘤微环境中的关键免疫细胞.
- 巨细胞衍生的EVs可以调节瘤行为,影响发展,转移,免疫逃避和化学抵抗.
研究的目的:
- 审查关于巨细胞衍生的EVs的文献.
- 讨论它们在调节瘤进展和治疗耐药性的作用.
- 探索使用这些电动汽车的新兴治疗策略.
主要方法:
- 关于巨细胞衍生的EVs研究的文献综述.
- 对EV类别和巨细胞极化亚型的分析.
- 在各种瘤类型中讨论EV功能.
主要成果:
- 巨细胞衍生的EV在瘤进展和转移中发挥着重要作用.
- 这些EVs影响免疫逃避和化学抵抗.
- 它们的功能可以根据巨细胞两极分化而依赖于上下文.
结论:
- 巨细胞衍生的EV是瘤微环境相互作用的关键调解者.
- 了解它们的多面性作用对于开发新型癌症疗法至关重要.
- 向来自巨细胞的EV为抗癌治疗策略提供了一个有前途的途径.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Overview of Exosomes
3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K


